Showing 541-550 of 4262 results for "".
New In My Practice: OTC
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-in-my-practice-otc-1/23302/NIH Analysis Examines Association Between AD and Comorbidities
https://practicaldermatology.com/programs/practical-dermatology-atopic-dermatitis/nih-analysis-examines-association-between-ad-and-comorbidities/27113/In this week's DermwireTV, new NIH data looks at the association between AD and several health conditions; a study evaluates the effect of lebrikizumab monotherapy in patients with moderate-to-severe AD over 16 weeks; and Andrew Mastro provides tips on how to optimize the first 5 minutes with a patiLow-Nickel Diets Show Promise for Contact Dermatitis
https://practicaldermatology.com/conferences/maui-derm-2024/low-nickel-diets-show-promise-for-contact-dermatitis/20256/Matthew Zirwas, MD, discusses his experience with the “low-nickel diet” for patients who have systemic reactions to dietary nickel.Practice Pearls for PDT
https://practicaldermatology.com/series/pdt-in-practice/practice-pearls-for-pdt/20213/Jill S. Waibel, MD a Miami dermatologist specializing in laser surgery, cosmetic dermatology, and medical dermatology, discusses her background in the use of photodynamic therapy (PDT) and provides insight into off-label PDT treatments she provides her patients. Dr. Waibel is a world-recognized leadThe Expanding Role for PD-1 Inhibitors for NMSCs
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-expanding-role-for-pd-1-inhibitors-for-nmscs/19937/The pool of potential patients that could be treated with PD-1 inhibitors is growing. Todd Schlesinger, MD discusses how these drugs may be used to treat a greater number of patients with NMSCs and addresses side effects and their management.Anatomy Lesson: Targeting the Underlying Cause of Wrinkles with Injections
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/anatomy-lesson-targeting-the-underlying-cause-of-wrinkles-with-injections/19778/Patients need to understand that addressing the underlying causes of wrinkles and folds such as changes in bony structures with injectables will provide a more natural result than simply chasing wrinkles and folds, says Jeanette M. Black, MD.IL-23 Inhibitors: Update on Safety and Dosing
https://practicaldermatology.com/topics/psoriasis/il-23-inhibitors-update-on-safety-and-dosing/19773/With more experience using IL-23 inhibitors to treat psoriasis, dermatologists are seeing high levels of patient satisfaction and no new safety signals. Jennifer Cather, MD assesses the clinical experience.Show and tell – infographic marketing tips for dermatologists
https://practicaldermatology.com/topics/practice-management/show-and-tell-infographic-marketing-tips-for-dermatologists/19693/Do you struggle to communicate research studies, statistics, aftercare instructions, and other complex ideas to your patients? This Ekwa Marketing video shows you how to simplify data and give it visual appeal with infographics.Check Mate: Ensuring Quality
https://practicaldermatology.com/topics/practice-management/check-mate-ensuring-quality/19677/To ensure consistency of care and that patients are properly prepped and cleared for treatment, Doris Day, MD has implemented checklists. She explains how the lists have improved staff management.Dupixent for Adolescents priority review, Restylane Lyft via cannulas, Hyperhidrosis Awareness
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-dupixent-for-adolescents-priority-review-restylane-lyft-via-cannulas-hyperhidrosis-awareness/18215/FDA grants priority review for Sanofi's and Regeneron's sBLA for Dupixent (dupilumab) for adolescents. Galderma's Restylane Lyft is approved for use with a small, blunt-tip cannula for cheek augmentation and the correction of age-related midface contour deficiencies in patients over the age of 21. T